Patents Assigned to Senescence Life Sciences Pte. Ltd.
  • Patent number: 11278519
    Abstract: Described herein are compositions and methods for the treatment and prevention of cognitive decline in subjects. Generally, among other potential components, the compositions comprise Centella asiatica or an extract thereof; ?-tocopherol or a derivative thereof; Ginseng or an extract thereof; a selenium compound, and ?-lipoic acid. Also provided are methods of making such compositions.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: March 22, 2022
    Assignee: Senescence Life Sciences Pte. Ltd.
    Inventor: Shawn Nathan Watson